This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Beat the Market Like Zacks: NVIDIA, Boeing, Rockwell Medical in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Factors Likely to Support Coca-Cola's (KO) Earnings Beat in Q4
by Zacks Equity Research
Coca-Cola's (KO) Q4 results are expected to reflect gains form growth across markets and categories, improved price/mix and strong brand portfolio.
COTY Q2 Earnings Surpass Estimates, Sales Decrease Y/Y
by Zacks Equity Research
COTY second-quarter fiscal 2023 results reflect improved earnings on higher adjusted net income. However, sales fall year over year.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Coty (COTY) Beats Q2 Earnings Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of 46.67% and 0.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Take the Zacks Approach to Beat the Market: Ulta Beauty, Clorox, Similarweb in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Clorox (CLX) Q2 Earnings and Sales Beat, Stock Rises 4.2%
by Zacks Equity Research
Clorox's (CLX) Q2 results reflect gains from strong demand trends, improved pricing, cost savings and strong execution, offset by lower volume and higher commodity costs.
Estee Lauder (EL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 19.38% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Cosmetic Stocks Likely to Top Earnings Estimates This Season
by Vrishali Bagree
Cosmetic companies gain from favorable demand and a focus on newness. The Estee Lauder Companies (EL), Coty (COTY) and Inter Parfums (IPAR) are likely to beat earnings estimates this season.
Is Inter Parfums (IPAR) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Inter Parfums (IPAR) and Coca-Cola FEMSA (KOF) have performed compared to their sector so far this year.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
If You Invested $1000 in Inter Parfums 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Are You Looking for a Top Momentum Pick? Why Inter Parfums (IPAR) is a Great Choice
by Zacks Equity Research
Does Inter Parfums (IPAR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Best Income Stocks to Buy for January 25th
by Zacks Equity Research
IPAR, DTEGY and PCRFY made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 25, 2023.
Inter Parfums (IPAR) Posts Robust Sales Numbers for Q4 & 2022
by Zacks Equity Research
Inter Parfums' (IPAR) fourth-quarter and full-year 2022 sales gain from the company's brand strength. Management remains encouraged about its prospects in 2023.
Prudent Partnerships & Growth Pillars Aid COTY, High Costs Ail
by Zacks Equity Research
COTY is benefiting from its focus on six strategic pillars of sustainable growth. The company is on track to mitigate the impact of inflation via cost savings.
Mondelez (MDLZ) Looks Tempting on Snacking Category Strength
by Zacks Equity Research
Mondelez (MDLZ) highlights that consumers continue to put snacking as a priority, even amid inflated costs and economic headwinds. The company remains well-placed for growth.
Best Growth Stocks to Buy for January 20th
by Zacks Equity Research
WTKWY, IPAR and KNBE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 20, 2022.
Procter & Gamble (PG) Beats Q2 Earnings & Sales Estimates
by Zacks Equity Research
Procter & Gamble (PG) Q2 results reflect gains from robust pricing and a favorable mix, mostly offset by elevated commodity and input costs, and currency headwinds.
Service Corporation (SCI) Gains on Expansion, Hurt by Cost Woes
by Zacks Equity Research
Service Corporation (SCI) has been benefiting from its focus on expansion and greater-than-expected funeral services performed. However, high costs are a concern.
Best Growth Stocks to Buy for January 18th
by Zacks Equity Research
WTKWY, IPAR and KNBE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 18, 2022.
Altria (MO) Troubled by High Costs, Soft Smokeable Volumes
by Zacks Equity Research
Altria Group (MO) has been troubled by cost woes and soft volumes in the Smokeable Products segment.
Helen of Troy (HELE) Troubled by Cost Woes & Soft Beauty Unit
by Zacks Equity Research
Helen of Troy (HELE) bears the brunt of escalated cost concerns and softness in the Beauty segment.
Best Growth Stocks to Buy for January 16th
by Zacks Equity Research
WTKWY, IPAR and KNBE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 16, 2022.
Are Consumer Staples Stocks Lagging Imperial Tobacco Group (IMBBY) This Year?
by Zacks Equity Research
Here is how Imperial Tobacco Group PLC (IMBBY) and Inter Parfums (IPAR) have performed compared to their sector so far this year.